Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...
Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...
What scientific knowledge is and is not presumed in legal reasoning, and what are the differences between what is and what is ...
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...
In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback